Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02674022 · ClinicalTrials.gov registry record · NA
Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT02674022: Completed NA study, sponsored by Mayo Clinic.
NCT02674022 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02674022, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this research study is to screen for metabolic abnormalities that are maternal risk factors for having a child with autism.
Interventions
- DIETARY_SUPPLEMENT Prenatal supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2016-01-20 |
| Est. Completion | 2018-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02674022
The ClinicalTrials.gov registry entry for NCT02674022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prenatal supplement is the first listed.
NCT02674022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02674022 about?
NCT02674022 is a clinical study titled "Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children". The purpose of this research study is to screen for metabolic abnormalities that are maternal risk factors for having a child with autism.
What is the current status of trial NCT02674022?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2016-01-20. Estimated completion is 2018-04-05.
What interventions are being tested in trial NCT02674022?
The interventions under investigation include: Prenatal supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02674022?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.